US Stock MarketDetailed Quotes

Relmada Therapeutics (RLMD)

Watchlist
  • 3.705
  • -0.095-2.50%
Trading Jan 16 14:25 ET
271.70MMarket Cap-2.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relmada Therapeutics (RLMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-55.12%10.33M
-45.69%10.22M
-20.75%18.22M
-19.10%83.89M
-28.90%19.08M
1.39%23.01M
-27.69%18.82M
-18.35%22.99M
-35.69%103.7M
-30.68%26.83M
Selling and administrative expenses
-46.95%6.29M
-8.59%7.4M
-35.27%6.27M
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
-General and administrative expense
-46.95%6.29M
-8.59%7.4M
-35.27%6.27M
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
Research and development costs
-63.80%4.04M
-73.70%2.82M
-10.18%11.95M
-15.75%46.18M
-25.43%11M
6.65%11.15M
-21.97%10.72M
-16.11%13.31M
-51.64%54.81M
-45.10%14.75M
Operating profit
55.12%-10.33M
45.69%-10.22M
20.75%-18.22M
19.10%-83.89M
28.90%-19.08M
-1.39%-23.01M
27.69%-18.82M
18.35%-22.99M
35.69%-103.7M
30.68%-26.83M
Net non-operating interest income expense
-71.16%247.01K
-66.62%321.46K
-58.30%440.29K
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
Non-operating interest income
-71.16%247.01K
-66.62%321.46K
-58.30%440.29K
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
Other net income (expense)
-102.62%-11.16K
-61.89%33.41K
110.58%218.68K
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
-115.60%-241.16K
213.60%404.94K
Gain on sale of security
-102.62%-11.16K
-61.89%33.41K
110.58%218.68K
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
94.98%-241.16K
213.60%404.94K
Income before tax
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
Income tax
Net income
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
Net income continuous Operations
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
Minority interest income
Net income attributable to the parent company
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
Basic earnings per share
58.33%-0.3
49.15%-0.3
19.44%-0.58
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
Diluted earnings per share
58.33%-0.3
49.15%-0.3
19.44%-0.58
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -55.12%10.33M-45.69%10.22M-20.75%18.22M-19.10%83.89M-28.90%19.08M1.39%23.01M-27.69%18.82M-18.35%22.99M-35.69%103.7M-30.68%26.83M
Selling and administrative expenses -46.95%6.29M-8.59%7.4M-35.27%6.27M-22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M
-General and administrative expense -46.95%6.29M-8.59%7.4M-35.27%6.27M-22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M
Research and development costs -63.80%4.04M-73.70%2.82M-10.18%11.95M-15.75%46.18M-25.43%11M6.65%11.15M-21.97%10.72M-16.11%13.31M-51.64%54.81M-45.10%14.75M
Operating profit 55.12%-10.33M45.69%-10.22M20.75%-18.22M19.10%-83.89M28.90%-19.08M-1.39%-23.01M27.69%-18.82M18.35%-22.99M35.69%-103.7M30.68%-26.83M
Net non-operating interest income expense -71.16%247.01K-66.62%321.46K-58.30%440.29K-31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M
Non-operating interest income -71.16%247.01K-66.62%321.46K-58.30%440.29K-31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M
Other net income (expense) -102.62%-11.16K-61.89%33.41K110.58%218.68K258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K-115.60%-241.16K213.60%404.94K
Gain on sale of security -102.62%-11.16K-61.89%33.41K110.58%218.68K258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K94.98%-241.16K213.60%404.94K
Income before tax 53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M
Income tax
Net income 53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M
Net income continuous Operations 53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M
Minority interest income
Net income attributable to the parent company 53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M
Basic earnings per share 58.33%-0.349.15%-0.319.44%-0.5819.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.83
Diluted earnings per share 58.33%-0.349.15%-0.319.44%-0.5819.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.24%
Sample Name
Sample Code
 +3.35%
Sample Name
Sample Code
 +2.77%
4
Clean Energy Fuels
CLNE
+1.59%
5
Block
XYZ
+1.22%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.60%
Sample Name
Sample Code
 +10.35%
Sample Name
Sample Code
 +9.51%
4
Kingsoft Cloud
KC
+7.04%
5
United Microelectronics
UMC
+6.20%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -